ClinicalTrials.gov
public full text
Public Domain
A Multicentre, Prospective, Open-label, Non-comparative Study
As there are no recent studies conducted in Italy on the profile of this COC, the purpose of this study is to evaluate its efficacy and tolerability in a given subset of women residing in Italy that are in need of contraception. Evaluate the cycle control: breakthrough bleeding (bleeding and/or spotting between cyclically regular onset of menses) of monophasic oral contraceptive pill Effimia® (NGM250 + EE35) in a population of women residing in Italy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Transitions between contraceptive states among women aged 15-49 Years in Guinea.#438979
- The Prevention Options for Women Evaluation Research (POWER) Cohort#847456
- A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy#1196435
- Demand for Modern Contraception in Sub-Saharan Africa: New Methods, New Evidence#939411
- ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial#800940
Record · ID 1443071
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive